Cognition Therapeutics (CGTX) Other Non-Current Liabilities (2020 - 2023)
Cognition Therapeutics (CGTX) posted quarterly Other Non-Current Liabilities of $1.1 million for Q2 2023, down 37.79% year-over-year from $1.7 million in Q2 2022, and down 40.36% quarter-over-quarter from $1.8 million in Q1 2023.
Cognition Therapeutics (CGTX) Other Non-Current Liabilities (2020 - 2023) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Other Non-Current Liabilities for 3 consecutive years, with $1.1 million the latest figure, recorded in Q2 2023.
- In Q2 2023, Other Non-Current Liabilities fell 37.79% year-over-year to $1.1 million; the TTM figure through Jun 2023 stood at $1.1 million (down 37.79% YoY), while the FY2022 annual figure was $1.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities slipped to $1.1 million in Q2 2023 per CGTX's latest filing, from $1.8 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $2.2 million in Q4 2020 and bottomed at $1.1 million in Q2 2023.
- Historically, Other Non-Current Liabilities has averaged $1.7 million across 3 years, with a median of $1.7 million in 2022.
- On a YoY basis, Other Non-Current Liabilities climbed as much as 5.42% in 2023 and fell as far as 37.79% in 2023.
- Cognition Therapeutics' Other Non-Current Liabilities stood at $2.2 million in 2020, then retreated by 23.68% to $1.7 million in 2022, then sank by 37.6% to $1.1 million in 2023.
- Business Quant data shows CGTX's Other Non-Current Liabilities at $1.1 million in Q2 2023, $1.8 million in Q1 2023, and $1.7 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.52 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 1.87 Mn |
| Dec 31, 2020 | 2.21 Mn |